PIP implants sold to Dutch firm under new name
Amsterdam, December 27, 2011
Potentially dangerous breast implants made by a now-defunct French company were sold to about 1,000 Dutch women under a different name, a Dutch health official said.
This revelation broadens a scandal that could affect some 300,000 women worldwide.
Dutch health authority spokeswoman Diane Bouhuijs said a Dutch company had bought implants made by France's Poly Implant Prothese, which went bankrupt in 2010 after French health authorities shut its doors and is now under investigation. The Dutch firm sold them in the Netherlands rebranded as "M-implants".
"We estimate that some 1,000 women in the Netherlands have those implants. We have advised them to consult their physician," Bouhuijs said. She declined to disclose the name of the Dutch company.
The rebranding of PIP implants potentially expands the scope of the health controversy in which PIP, once the third-largest maker of breast implants in the world, stands accused of using industrial-grade instead of medical-grade silicone in some of its protheses. They were sold in a number of European and Latin America countries.
The company's founder, Jean-Claude Mas, was able to charge lower prices for the implants using the non-approved silicone.
Health authorities have cited no evidence of increased cancer risk due to the PIP implants but have said they have higher rates of rupture that could cause inflammation and irritation.
While the French government has urged the 30,000 women in France with PIP implants to have them removed, other countries, including Britain and Brazil, say women should visit their surgeons for checks.
Health spokeswoman Bouhuijs did not say how long M-implants were sold in the Netherlands before they were banned in March 2010, along with PIP-labeled implants, as in France.
In early 2010 Dutch authorities launched an investigation into breast implants which is still going on, Bouhuijs said.
France's drug and medical device regulator, AFSSAPS, was closed on Monday due to the holiday, so Reuters was unable to ascertain whether health authorities knew about the M-implants.
Mas' lawyer Yves Haddad told Reuters on Monday that his 72-year-old client is in poor health but ready to respond to any court summons. No one has been charged in the case, but sources say a Marseilles court could soon announce fraud charges against four to six ex-PIP employees.
An investigation into involuntary homicide is going on, following the death from cancer in 2010 of a woman who had PIP implants. Haddad denied that Mas was in hiding, reiterating that he was still in southern France's Var region.
"He's currently in very bad health because he has just undergone a difficult surgery that prevents him from walking," Haddad said.
Mas recent surgery was confirmed by a second source, who cited a vascular problem. "He is worried by the importance this matter is taking on.
He is angry at those who pointlessly add to people's suffering," Haddad said.
Haddad denied reports that Mas was a former butcher, saying that before founding PIP in 1991 he worked for more than 15 years as a medical sales representative for Bristol Myers. - Reuters
More Health & Environment Stories
- SARS virus claims one more victim in Saudi
- New support group comes to overeaters' rescue
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference